For Norwood II–III Men Who Keep Putting Off AGA Treatment Because ‘It’s Still Mild’ — Dr. Moriwaki Clarifies When to Start Early-Stage Hair Regenerative Medicine With Stem Cell Conditioned Media and When It’s Reasonable to Wait a Little Longer2026.08.08

“I’m still only around Norwood II or III on the classification, so I don’t need to rush into treatment” — many men delay their AGA consultation for months or even years with this thinking. But when you start early-stage hair regenerative medicine can be the branching point that determines your hair volume over the next 10 to 20 years. In this column, Dr. Moriwaki of AVAN TOKYO Ginza organizes how to draw the line between ‘start now’ and ‘wait a little longer,’ from three perspectives: rate of progression, remaining follicular reserve, and the role of stem cell conditioned media.

Key Points of This Article

・Early-stage hair regenerative medicine should be timed based on ‘rate of progression,’ not on waiting until symptoms are fully developed

・Even with mild Norwood II–III, when family history, retreat speed, and miniaturization signs align, ‘start now’ can be more advantageous than ‘wait’

・Stem cell conditioned media is a treatment that intervenes in the follicular microenvironment while follicles still exist — its target range narrows in end-stage AGA

・For those hitting a plateau on oral monotherapy, it is worth considering as a complementary option that supports the follicular environment in parallel

・Any ‘watch and wait’ period justified by ‘it’s still mild’ should be capped at about six months, and standardized photos with a progression-speed record kept during that time provide the material for later judgment

The time axis that men putting off treatment ‘because it’s still mild’ tend to overlook

While AGA often progresses gradually, there is also a certain share of men in their late 20s to 30s whose AGA advances rapidly as if a switch were flipped. The reassurance that ‘at Norwood II–III no one around me really notices’ tends, in practice, to delay the start of treatment.

The important perspective is not ‘how it looks right now’ but ‘how much has receded over the past year’ — the time derivative. A few millimeters of hairline recession, or an expanded area of visible scalp at the crown, are exactly the changes the individual notices last. Many first realize when a family member or barber points it out. If you don’t measure by the time derivative, you often ‘realize you’ve reached a stage where it’s hard to go back’ — this is the tricky nature of AGA.

Signs that call for early treatment even when ‘mild’

A strong AGA family history on both paternal and maternal sides, clear recession already visible in the late 20s to early 30s, and hair caliber variability or miniaturization becoming noticeable on microscopy — these are not ‘still fine because it’s mild’ but rather signs that call for early consideration of treatment, including early-stage hair regenerative medicine. Conversely, if these are absent and there is little photographic progression, the short-term watch-and-wait discussed below becomes a valid option.

The medical meaning of ‘starting now’ in early-stage hair regenerative medicine

In AGA, testosterone is converted to DHT (dihydrotestosterone) by 5-alpha reductase, and susceptible follicles gradually undergo miniaturization. Miniaturized follicles have a shortened anagen phase, thick long hair is replaced by thin short hair, and ultimately the follicles themselves move toward disappearance.

What is important to grasp here is the concept of ‘tuning the follicular microenvironment while follicles still exist.’ The various growth factors contained in stem cell conditioned media (IGF-1, KGF, VEGF, HGF, and others) are thought to act on the signaling environment of follicular stem cells and dermal papilla cells, and are used with the intent of supporting the microenvironment that sustains the anagen phase of the hair cycle. This is precisely why early intervention through early-stage hair regenerative medicine is often described as medically rational.

Options narrow ‘after follicles are gone’

In scalps that have progressed to Norwood VI–VII, the follicles themselves are absent across wide areas, and injecting stem cell conditioned media cannot ‘generate new hair from nothing there.’ The central goal remains ‘protecting the follicles that remain and supporting the anagen phase,’ so the addressable range narrows as the stage advances. Because of this structure, early-stage hair regenerative medicine has a timing-race dimension aimed at protecting the pre-progression follicular asset.

Some men are appropriate candidates for ‘wait a little longer’

On the other hand, some men worried about the appearance of Norwood II–III are actually only in age-related mature hairline recession. In this case, while the hairline may look receded compared to the teenage years, some patterns progress hardly at all over the following years.

The judgment to ‘wait and see’ is relatively appropriate when the following align: weak family history, no clear photographic recession over the past year, and few miniaturization signs on microscopy. But even then, it is essential to objectively record the progression speed with standardized photos every 3 to 6 months and to be prepared to quickly switch to starting treatment the moment changes appear. ‘Wait and see’ should not mean ‘leave alone’ — the premise must be ‘continue to measure the course.’

How to position stem cell conditioned media within ‘mild AGA’

In early-stage hair regenerative medicine, stem cell conditioned media is not in opposition to standard treatments such as oral finasteride and dutasteride or topical minoxidil, but is considered as a complementary option that tunes the follicular microenvironment in parallel. For those with mild AGA already on anti-androgen medication for progression control, scalp injection or drug delivery treatment can become a two-tier option: ‘stop the progression + support the follicular environment.’

That said, effects vary between individuals, and there is no universal guarantee of regrowth at any Norwood stage. The basic approach is to share the indications and limitations with the physician and to perform effect assessment in six-month units. For more information, please also see other articles at related columns on hair regenerative medicine. General guidance on AGA management can also be found in the guidelines of the Japanese Dermatological Association.

Frequently Asked Questions

Q. Is there meaning in receiving stem cell conditioned media treatment even at mild Norwood II?

Medically, the concept of ‘tuning the follicular microenvironment while follicles still exist’ holds well, and for rapidly progressing types or those with strong family history it can be a meaningful option. However, since it is not a treatment that guarantees regrowth for everyone, please decide with your physician after sharing indications and limitations.

Q. Is it acceptable to wait and see for six months to a year because ‘it’s still mild’?

If family history is weak, there is little recession on photo comparison, and no miniaturization signs, short-term watch-and-wait is reasonable. But during that period we recommend keeping standardized photos and microscopy records so you can quickly switch to treatment the moment changes appear.

Q. Between early-stage hair regenerative medicine and oral treatment, which should be started first?

Generally, anti-androgen medications like finasteride or dutasteride are used first to establish a foundation of progression control, and stem cell conditioned media is then combined to support the follicular environment in parallel. The order is decided with the physician based on individual progression, preferences, and side-effect risk.

Q. When should effects be assessed after starting treatment?

Due to the hair cycle, the material for judgment consists of standardized photos and microscopy findings at three to six months at the earliest. Concluding ‘it’s not working’ after one or two months is too early, while continuing by inertia for years is also to be avoided.

Q. If I start treatment, will things revert to how they were if I stop midway?

Because AGA is a progressive condition, discontinuing treatment can gradually shift things back toward progression over time. You need not continue at the same intensity forever, but the basic approach is to adjust to a maintenance-phase protocol and continue.

──────────────

【Medical Supervisor】Shin Moriwaki (Supervising Physician)

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries welcomed via DM / LINE / Website / Phone.